The current valuation score of NanoViricides Inc is 6.06, ranking 360 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -3.11, which is -58.62% below the recent high of -1.29 and -37.78% above the recent low of -4.28.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.